Cross-sectional and longitudinal analysis of cancer vaccination trials registered on the US Clinical Trials Database demonstrates paucity of immunological trial endpoints and decline in registration since 2008
Liangjian Lu,1 Haixi Yan,1 Vijay Shyam-Sundar,1 Tobias Janowitz2 1School of Clinical Medicine, 2Cancer Research UK, Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, UK Introduction: Cancer vaccination has been researched as a means of treating and preventing cancer, but...
Main Authors: | Lu L, Yan H, Shyam-Sundar V, Janowitz T |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2014-09-01
|
Series: | Drug Design, Development and Therapy |
Online Access: | http://www.dovepress.com/cross-sectional-and-longitudinal-analysis-of-cancer-vaccination-trials-peer-reviewed-article-DDDT |
Similar Items
-
Discrepancies in endpoints between clinical trial protocols and clinical trial registration in randomized trials in oncology
by: Victoria J. Serpas, et al.
Published: (2018-12-01) -
Trial design and analysis of endpoints in HIV vaccine trials
by: Richert, Laura
Published: (2013) -
Informative noncompliance in endpoint trials
by: Iglewicz Boris, et al.
Published: (2004-07-01) -
Analysis of ayurvedic clinical trials registered in clinical trials registry of india: retrospective versus prospective registration
by: Pravin M Bolshete
Published: (2017-01-01) -
The analysis of multiple endpoints in clinical trials
by: James, Susan Elizabeth
Published: (1993)